Read More Pharma Industry News Glenmark Therapeutics takes on Pataday with new OTC eye solution—what you need to know Glenmark Therapeutics Inc., USA, has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% (OTC), marking a significant development in… byPallavi MadhirajuAugust 20, 2024